State of Michigan Retirement System’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-324,028
Closed -$27.1M 977
2020
Q4
$27.1M Buy
324,028
+224,327
+225% +$13.6M 0.19% 122
2020
Q3
$3.57M Buy
+99,701
New +$3M 0.03% 412

Other funds holding DNLI

State of Michigan Retirement System's DNLI Position: Q1 2021 in Review

State of Michigan Retirement System sold out of Denali Therapeutics (DNLI) in Q1 2021, closing a stake of 324,028 shares — an estimated $27.1M sold.

State of Michigan Retirement System first reported a position in DNLI in Q3 2020 and held it in 2 quarters. The position peaked at $27.1M in Q4 2020. 216 funds tracked by Wall St. Rank hold DNLI as of Q1 2021.

  • State of Michigan Retirement System reported no remaining Denali Therapeutics position as of Q1 2021 after selling out during the quarter.
  • State of Michigan Retirement System sold 324,028 Denali Therapeutics shares in Q1 2021, an estimated $27.1M.
  • State of Michigan Retirement System first reported a position in Denali Therapeutics in Q3 2020 and held it in 2 quarters.
  • State of Michigan Retirement System's Denali Therapeutics position peaked at $27.1M in Q4 2020.
  • 216 funds tracked by Wall St. Rank held Denali Therapeutics as of Q1 2021.

Based on State of Michigan Retirement System's 13F filing for Q1 2021, filed 3 May 2021.